Fox Chase Cancer Center News

PHILADELPHIA (August 12, 2024) — Differentiation therapy is a relatively new approach to treating cancer that works by “normalizing” cancer cells. Now a study published today by Fox Chase Cancer Center researchers demonstrates that this approach could be an effective treatment for medulloblastoma, a malignant brain tumor.

PHILADELPHIA (August 5, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Michael Seidman, MD, as a Professor in the Department of Hematology/Oncology.

PHILADELPHIA (August 6, 2024) — Jonathan Chernoff, MD, PhD, Cancer Center Director at Fox Chase Cancer Center, has been named a Fellow of the American Society for Cell Biology (ASCB).

PHILADELPHIA (August 5, 2024) — Richard Bleicher, MD, FACS, a Professor in the Department of Surgical Oncology and Clinical Director of the Breast Service Line, has been promoted to Chief of the new Division of Breast Surgery at Fox Chase Cancer Center.

Fox Chase Cancer Center is pleased to announce the hiring of Aitziber Buque Martinez, PhD, as an Assistant Professor in the Cancer Signaling and Microenvironment Research Program.

PHILADELPHIA (July 29, 2024) — In a study published today, researchers at Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University have identified factors that, if addressed, could decrease incidence of aggressive prostate cancer in areas where rates are highest — often Black communities with high rates of poverty.

PHILADELPHIA (July 25, 2024) — Fox Chase Cancer Center was recently recognized by the American College of Surgeons (ACS) as a Surgical Quality Partner through participation in the organization’s Commission on Cancer and National Surgical Quality Improvement Program (NSQIP).

PHILADELPHIA (July 23, 2024) — A new study published in the prestigious journal Nature Communications by researchers from the Lewis Katz School of Medicine at Temple University and the Fox Chase Cancer Center sheds light on how protein phosphatases target proteins and help regulate cell cycle progression, work that could help lay the groundwork for potential new targets for cancer therapies.